The Role of Patents, Universities, and Non-Profits in the Promotion of Health Care Access Nina Gandhi.

Slides:



Advertisements
Similar presentations
David M. Pollock Medical College of Georgia Discovery-Academia.
Advertisements

Patient Choice Act ….for those you love.
Technology and Economic Development Intellectual Property Issues in Research Jim Baker Director Office of Technology and Economic Development
Efficiency, Ethics and Cost in Pharmaceutical Research and Manufacturing Matthew Wirtala Spring 2006.
The Global Access to Medicines Movement Peter Maybarduk April 15, 2011.
Principal Patent Analyst
Intellectual Property Rights Margaret Lawlor Business Development Manager Faculty of Medical Sciences 2015 copyright©NewcastleUniversity 2015.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Possible Impact of Market Exclusivity Extension on Pharmaceuticals in Thailand Chutima Akaleephan International Health Policy Program, Thailand 27 August.
An Overview of the Canadian Pharmaceutical Industry
The Global Generic Medications Market
Technology Transfer: The NIH Experience Steven M. Ferguson, CLP Deputy Director, Licensing & Entrepreneurship Office of Technology.
What role to universities play in biomedical research and development? In the US, most basic biomedical research is performed at universities and funded.
Introduction to Intellectual Property using the Federal Acquisitions Regulations (FAR) To talk about intellectual property in government contracting, we.
Title here Taking Discoveries from Lab Bench to the Marketplace Technology Transfer 101:
Vilnius Lithuania BSc.: Biochemistry Neuropsychology J.D.: University of Oregon LL.M.:University College London Pacific Northwest National Laboratory.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
IP for Scientists Universities Allied for Essential Medicines (UAEM) UC Berkeley.
Pharmaceutical Industry Analysis Nature of the industry: Highly defensive and 15% of U.S. population aged over 60→Highly mature. Main forces are the suppliers,
The Role of Universities Amit Khera MS-1 University of Pennsylvania School of Medicine Adapted from presentation by Hillary Freudenthal & Sam Chaifetz.
WIPO Dispute Resolution in International Science & Technology April 25, 2005 Ann M. Hammersla Senior Counsel, Intellectual Property Massachusetts Institute.
Overview OTL Mission Inventor Responsibility Stanford Royalty Sharing Disclosure Form Patent View Inventor Agreements Patent.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
International IP Regime and A2M : Role of BRICS K M Gopakumar TWN.
 .
Relationship of FFSP to the Florida Agricultural Experiment Station John P. Hayes August 6, 2012.
1 Knowledge | Innovation | Technology Overview of Risk Management in University Technology Transfer David N. Allen, Ph.D. Associate Vice President for.
Intellectual Property Rights Margaret Lawlor Business Development Manager Faculty of Medical Sciences 3rd October 2013 copyright©NewcastleUniversity 2013.
Bridging Gap in Global Innovation – From need to Access, Said Business School, University of Oxford 9-13 September 2007 Strategies for Managing Innovation.
Essential Medicines and the University Challenge: Promoting Local Research for Global Impact For more information, please visit: UAEM home page:
Intellectual Property and Innovation … The Virtuous Cycle Khaled Mansour Area Managing Director, Janssen, Middle East, West Asia and Africa.
1 Intellectual Property in the Innovative Pharmaceutical Industry *** June 12, 2006 Gregg C. Benson Assistant General Counsel – Intellectual Property 1.
UNCTAD/CD-TFT 1 Intellectual Property Rights and National Development Goals – Ensuring Innovation in Russia St. Petersburg/Moscow Study Tour 2008 Christoph.
Patents and Medicines: How the system has discouraged innovation and reduced patient access to benefits of knowledge GREG PERRY Director General, EGA World.
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
Government Funded Inventions Mark L. Rohrbaugh, Ph.D., J.D. Acting Director Office of Technology Transfer National Institutes of Health.
NIH Funding Recipient Responsibilities February, 2004 Office of Technology Transfer Office of the Director National Institutes of Health.
ACCESS TO MEDICINES - POLICY AND ISSUES
© IFPMA 2009WIPO Open-ended Forum on Proposed Development Agenda Projects - 13/10/2009 IFPMA views on the strategic use of information for sustainable.
Intellectual Property Rights and Pharmaceuticals (Following Up the ‘Novartis case’ ) Background note prepared for PHM Vic Internet Workshop.
What are Drug Royalties?  Rights on the sales of different prescriptions drugs.
Ignite Technology Transfer NUI Galway Technology Transfer Office Seamus Coyne, Ph.D Neil Ferguson, Ph.D Commercialisation Executives Technology Transfer.
Ellen ‘t Hoen Médecins sans Frontières
Academic Technology Transfer Operations and Practice Knowledge Economy Forum IV Istanbul, Turkey March 22-25, 2005 Alistair Brett Oxford Innovation.
Protection of Intellectual Property in Canada George Jackowski, Ph.D., KCTJ October 19 th, 2015 Chairman of NAVA Corp.
Wyoming Research Products Center Technology Transfer and Licensing Senator Enzi’s Inventors Conference April 20, 2013 Phillip Wulf, Intellectual Property.
INTELLECTUAL PROPERTY 101 CHASE KASPER, DIRECTOR OFFICE OF TECHNOLOGY DEVELOPMENT
Technology Transfer in The United States Paul Zielinski Director, Technology Partnerships Office, National Institute of Standards and Technology Chair,
Issues related to poor IP protection in EMs: Pharmaceutical Example Rob May Commercial Director, Janssen, EMEA Emerging Markets.
McGraw-Hill/Irwin © 2002 The McGraw-Hill Companies, Inc., All Rights Reserved. Chapter 23 The Economics of Prescription Drugs.
The Role of New Markets Advisors in Healthcare Case Study in Pharma.
ARRRR! Drug Development and Discovery Access to Essential Medicines De-Cal Fall Week 2.
Balancing revenues and costs for orphan drugs: a case study Aidan Hollis University of Calgary: Department of Economics and O’Brien Institute of Public.
U.S. Licensing Regulation as a Model for Developing Countries Benton Martin Emory University School of Law Juris Doctor Candidate 2010.
Competition and Intellectual Property Protection in the Pharmaceutical Sector Alexey Ivanov Director, HSE-Skolkovo Institute for Law and Development Director,
Intellectual Property And Data Rights Issues Domestic & Global Perspectives Bayh-Dole act -- rights in data Henry N. Wixon Chief Counsel National Institute.
Clinical Trials.
iHEA 9th World Congress Sydney, July 8, 2013
Topic and Country Assignments
Topic and Country Assignments
Universities and the Commercial World
Intellectual Property Protection and Access to Medicines
Clinical Trials — A Closer Look
Taking Discoveries from Lab to Marketplace
Prescription for Pharmaceutical Reform: Healing an Ailing System
Obligation to contribute to R&D costs Use of pharmaceutical inventions without authorization of patent owners James Love. CPTech 16 April 2004 Twelfth.
The Bayh–Dole Act: Where Are We Today?
Pharmaceuticals Industry
Expert Speak: How Pharma Companies Can Grow Their Business?
Presentation transcript:

The Role of Patents, Universities, and Non-Profits in the Promotion of Health Care Access Nina Gandhi

From the Lab to the Marketplace Major players:  Public Research Institutions

From the Lab to the Marketplace Major players:  Public Research Institutions  Pharmaceutical Research Institutions

From the Lab to the Marketplace Major players:  Public Research Institutions  Pharmaceutical Research Institutions  Pharmaceutical companies

From the Lab to the Marketplace Major players:  Public Research Institutions Pharmaceutical Research Institutions  Pharmaceutical companies  ** Universities and Non-profit organizations

Key Terms: What is a patent?  A patent grants an inventor sole rights to an invention for a given amount of time. wordnet.princeton.edu/perl/webwn z/v/side_GreenIdea.jpg

Key Terms: What is a patent?  A patent grants an inventor sole rights to an invention for a given amount of time.  Drugs on patent = EXPENSIVE, exclusive  Drugs off patent = generic, normally inexpensive wordnet.princeton.edu/perl/webwn

Key Terms: What is licensing?  Licensing refers to contractual agreements granting permission for the use of intellectual property under specific conditions. place.wa.us/Business%20Licensing/business.jpg

Key Terms: What is the Bayh-Dole Act?  A way for a university or non-profit to own rights to its research and license out these rights Story_Bayh-Dole.jpg

Key Terms: What is the Bayh-Dole Act?  A way for a university or non-profit to own rights to its research and license out these rights  Bypasses government institutions ** Story_Bayh-Dole.jpg

Key Terms: What is the Hatch-Waxman Act?  Allows generic drugs into the market before patents expire. org/uploaded_images/Pres cription%20Drugs.jpg

Key Terms: What is the Hatch-Waxman Act?  Allows generic drugs into the market before patents expire.  Created ANDA process shared/Editor/assets/court_ room.jpg

Key Terms: What are the FDA and FTC?  FDA  Center for Drug Evaluation and Research

Key Terms: What are the FDA and FTC?  FDA  Center for Drug Evaluation and Research  Evaluates scientific research

Key Terms: What are the FDA and FTC?  FDA  Center for Drug Evaluation and Research  Evaluates scientific research  Approves of safety of drugs

Key Terms: What are the FDA and FTC?  FTC  Enforce “true in advertising” claims

Key Terms: What are the FDA and FTC?  FTC  Enforce “true in advertising” claims  Bureau of Competition

Key Terms: What are the FDA and FTC?  FTC  Enforce “true in advertising” claims  Bureau of Competition  Monitors relationship between drug companies and generics

From the Lab to the Marketplace Drug Research and Conception FDA Approval (NDA) Clinical Trials, Testing ($$$ and time) Patented Drug (lasts years) Availability of Generics BIG PHARMA + GOV’T REVENUE

The Role of Universities

Domestic Research, Outsourced Drug Rights  Universities receive funding through grants and awards. wu/images/money%203.jpg e/images/video-award-shelf.jpg

Domestic Research, Outsourced Drug Rights  Universities receive funding through grants and awards  Government makes an investment in research and expects new discoveries. content/uploads/government- grants.jpg

Domestic Research, Outsourced Drug Rights  The innovations are shared with Technology Transfer Offices (TTO’s)  Research patented by the university is licensed to pharmaceutical companies for production systems.sartoserver.de/media/ productpics/bioscipro_(novo)_ 23_copy.jpg

What Can Be Improved? Implications for Developing Countries and Accessible Global Health  AUTM’s 9th point  Universities should use research money for neglected diseases city.com/files/aa/32997/p/f/pov erty_3_0146.gif

What Can Be Improved? Implications for Developing Countries and Accessible Global Health  AUTM’s 9th point  Universities should use research money for neglected diseases  Ensure that underprivileged populations have access to these medicines ages/Africa_poverty-383x480.png

What Can Be Improved? Implications for Developing Countries and Accessible Global Health  Organizations that promote point #9:  Technology Managers for Global Health  Universities Allied for Essential Medicines ey.edu/image005.j pg

Role of Non-profit Companies (not an oxymoron anymore!)  Benefits of non-profit pharmaceutical companies  R&D team

Role of Non-profit Companies (not an oxymoron anymore!)  Benefits of non-profit pharmaceutical companies  R&D team  Research, clinical trials, prepare paperwork, etc.

Role of Non-profit Companies (not an oxymoron anymore!)  Benefits of non-profit pharmaceutical companies  R&D team  Research, clinical trials, prepare paperwork, etc.  No obligation to a specific demographic

Non-profit Example: Carolina Vaccine Institute  Develops vaccines for neglected diseases for developing countries

Non-profit Example: Carolina Vaccine Institute  Develops vaccines for neglected diseases for developing countries  Uses revenue to fund more research

Non-profit Example: Carolina Vaccine Institute  Develops vaccines for neglected diseases for developing countries  Uses revenue to fund more research  An example of universities and non-profits for the promotion of global health

From the Lab to the Marketplace Drug Research and Conception FDA Approval (NDA) Clinical Trials, Testing ($$$ and time) Patented Drug (lasts years) Availability of Generics BIG PHARMA + GOV’T REVENUE

How Universities and Non-profit Companies Fit In Drug Research and Conception FDA Approval (NDA) Clinical Trials, Testing ($$$ and time) Patented Drug (lasts years) Availability of Generics BIG PHARMA + GOV’T REVENUE Reduced $$$ and time Production and Distribution REVENUE University Research and Work of TTOs

What WE Can Do!  "When it comes to global health, there is no 'them'... only ' us.'" - Global Health Council